What is Cimziatm?
Cimziatm (certolizumab pegol, CDP870) is a drug being made for use in the treatment of patients with Crohn's disease. When approved, CIMZIA(TM) will represent the first and only biologic administered by monthly subcutaneous injection as a treatment for Crohn's disease patients.